Stay updated with breaking news from Clb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Core Laboratories (NYSE:CLB – Get Free Report) issued an update on its first quarter 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.140-0.180 for the period, compared to the consensus earnings per share estimate of 0.190. The company issued revenue guidance of $122.0 million-$128.0 million, compared to the consensus […] ....
Core Laboratories (NYSE:CLB – Get Free Report) had its target price dropped by research analysts at Stifel Nicolaus from $23.00 to $21.00 in a research note issued on Monday, Benzinga reports. The brokerage presently has a “hold” rating on the oil and gas company’s stock. Stifel Nicolaus’ price objective would indicate a potential upside of […] ....
Bank of New York Mellon Corp trimmed its position in Core Laboratories Inc. (NYSE:CLB – Free Report) by 8.8% in the third quarter, according to its most recent filing with the SEC. The fund owned 366,254 shares of the oil and gas company’s stock after selling 35,273 shares during the period. Bank of New York […] ....
Core Laboratories Inc. (NYSE:CLB – Get Free Report) shot up 5.6% on Wednesday . The company traded as high as $16.42 and last traded at $16.30. 238,827 shares changed hands during trading, a decline of 58% from the average session volume of 572,957 shares. The stock had previously closed at $15.44. Analyst Ratings Changes A […] ....
Core Laboratories Inc. (NYSE:CLB – Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 6,340,000 shares, a growth of 16.5% from the November 30th total of 5,440,000 shares. Currently, 13.7% of the company’s stock are sold short. […] ....